Gene therapy demand drives VGXI to up Texan GMP capabilities – BioPharma-Reporter.com
BioPharma-Reporter.com |
Gene therapy demand drives VGXI to up Texan GMP capabilities
BioPharma-Reporter.com The new capabilities come as a response to growing demand for gene therapy products, business development manager Christy Franco told Biopharma-Reporter. “Specifically plasmid raw material for viral vector production such as for AAV based products and … |
